DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 01 · Volume 56 · January 2018 DOI: 10.1055/s-007-35562

Deutsche Arbeitsgemeinschaft zum Studium der Leber
34. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Hamburg, 26.–27.01.2018

Kongresspräsident: Prof. Dr. Ansgar Lohse

A2.4
Hamesch, K; Heimes, C; Mandorfer, M; Moeller, L; Pereira, V; Pons, M; Reichert, M; Woditsch, V; Voß, J; Bretag, T; Spivak, I; Arslanow, A; Krawczyk, M; Wetzel, M; Siegmund, B; Aigner, E; Schaefer, B; Zoller, H; Reiberger, T; Yagmur, E; Gleiber, W; Bals, R; Koczulla, A; Miravittles, M; Janciauskiene, S; Bzdok, D; Genesca, J; Lammert, F; Trauner, M; Krag, A; Trautwein, C; Strnad, P: Liver Fibrosis and Metabolic Alterations in Adults with Homozygous Alpha1-antitrypsin Deficiency (PiZZ Genotype)
A2.5
Liwinski, T; Heinsen-Groth, F; Rühlemann, M; Zenouzi, R; Kummen, M; Hov, J; Karlsen, T; Bang, C; Lohse, A; Franke, A; Schramm, C: The intestinal microbiota of patients with PSC are different from healthy controls and patients with ulcerative colitis across geographical regions
A2.7
Strnad, P; Buch, S; Hamesch, K; Fischer, J; Heimes, C; Gutberlet, M; Janciauskiene, S; Mandorfer, M; Trauner, M; Reichert, M; Krawczyk, M; Lammert, F; Deltenre, P; Schafmayer, C; Nothnagel, M; Aigner, E; Datz, C; Stickel, F; Morgan, M; Hampe, J; Berg, T; Trautwein, C: Heterozygous carriage of the alpha1-antitrypsin PiZ variant increases the risk to develop liver fibrosis
A2.8
Hartl, J; Wong, G; Zachou, K; Ashgar, A; Pape, S; Sebode, M; Peiseler, M; Weiler-Normann, C; Zenouzi, R; Krech, T; Ehlken, H; Huebscher, S; Miquel, R; Schramm, C; Drenth, J; Oo, Y; Dalekos, G; Heneghan, M; Lohse, A: Autoimmune hepatitis with normal IgG at diagnosis: Subtype without selective elevation of IgG but similar histological features and treatment response
A2.9
A2.10
Rausch, V; Silva, I; Peccerelle, T; Mueller, S: Masked-hemolysis as novel cause of hepatic iron overload in ALD
A2.11
Wächter, L; Haderer, M; Aschenbrenner, E; Pollinger, K; Schlosser, S; Kunst, C; Müller-Schilling, M: Interactions of gut epithelial barrier, microbiome and p53 family members – what is their impact on liver cirrhosis?
A2.12
Hippchen, T; Sauer, P; Schirmacher, P; Süsal, C; Weiss, K; Gotthardt, D; Stremmel, W; Rupp, C: Hypergammaglobulinemia predicts outcome in patients with primary sclerosing cholangitis
A2.13
Giesler, M; Bettinger, D; Rössle, M; Thimme, R; Schultheiss, M: Efficacy of variceal embolisation in patients with TIPS implantation: a propensity score analysis
A2.14
Krawczyk, M; Bantel, H; Rau, M; Schattenberg, J; Grünhage, F; Pathil, A; Weber, S; Demir, M; Kluwe, J; Boettler, T; Geier, A; Lammert, F: Could inherited predisposition drive fatty liver disease in non-obese Germans? Results from eight tertiary referral centers
A2.16
Sebode, M; Kloppenburg, A; Aigner, A; Lohse, A; Linder, R; Schramm, C: Prevalence and “real-life” treatment of autoimmune liver diseases in Germany
A2.18
Wang, M; Wandrer, F; Schlué, J; Voigtländer, T; Lankisch, T; Manns, M; Bantel, H; Hahn, T von: Transjugular diagnostics in fulminant hepatitis including measurements of hepato-central venous biomarker gradients
A2.19
Büchter, M; Manka, P; Heinemann, F; Lindemann, M; Baba, H; Schlattjan, M; Canbay, A; Gerken, G; Kahraman, A: Triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis – investigations on 565 patients
A2.21
Mueller, J; Raisi, H; Rausch, V; Simons, D; Ziener, C; Schlemmer, H; Seitz, H; Straub, B; Waldburger, N; Mueller, S: Comparison between Room-temperature susceptometry and MRI with respect to the cell-specific detection of liver iron
A2.22
Bettinger, D; Gkika, E; Schultheiss, M; Glaser, N; Lange, S; Maruschke, L; Buettner, N; Kirste, S; Nestle, U; Grosu, A; Thimme, R; Brunner, T: Comparison of local tumor control in patients with HCC treated with stereotactic body radiation or TACE: a propensity score analysis
A2.23
Drolz, A; Wolter, S; Wehmeyer, M; Piecha, F; Horvatits, T; Schulze zur Wiesch, J; Lohse, A; Mann, O; Kluwe, J: Aussagekraft nicht-invasiver Verfahren zur Fibrosequantifizierung bei NAFLD-Patienten mit moderater versus morbider Adopisitas
A2.24
A2.25
Labenz, C; Baron, J; Schill, C; Huber, Y; Nagel, M; Galle, P; Schattenberg, J; Wörns, M: Das Vorliegen einer minimalen hepatischen Enzephalopathie reduziert die Lebens- und Schlafqualität von Patienten mit Leberzirrhose
A2.27
Piecha, F; Steins, D; Drolz, A; Wehmeyer, M; Horvatits, T; Spink, C; Ittrich, H; Lohse, A; Kluwe, J: Persistierender Aszites nach TIPS-Implantation ist prädiktiv für ein geringeres transplantationsfreies Überleben bei Patienten mit Leberzirrhose
A2.28
Abdulkarim, M; Jung, F; Schluz, L; Hartl, J; Zenouzi, R; Lohse, A; Schramm, C; Weiler-Normann, C: Gender as a negative prognostic factor in Primary biliary cholangitis
A2.29
Jamka, M; Arslanow, A; Bohner, A; Krawczyk, M; Weber, S; Grünhage, F; Lammert, F; Stokes, C: Effects of gene variants controlling vitamin D metabolism and serum levels on hepatic steatosis
A2.30
Al-Herwi, E; Stengel, S; Golembiewski, C; Steube, A; Stallmach, A; Bruns, T: TLR9-mediated immune sensing of bacterial DNA in decompensated cirrhosis is stage-dependent
A2.31
Wehmeyer, M; Sekhri, H; Wroblewski, R; Galante, A; Meyer, T; Lohse, A; Schulze zur Wiesch, J: Bestimmung der „pitted erythrocytes“ als Marker einer funktionellen Hyposplenie bei Patienten mit Leberzirrhose
A2.33
Mahli, A; Koch, A; Thasler, W; Hellerbrand, C: Hepatic steatosis potentiates irinotecan-induced hepatocellular injury
A2.34
Büchter, M; Manka, P; Thimm, J; Best, J; Gerken, G; Baba, H; Kahraman, A: Enzymatic liver function measured by LiMAx correlates well with histology in patients with chronic liver disease
A2.36
Goonoo, M; Beresford, H; Gleeson, D; Salmon, C: How well are we managing decompensated liver cirrhosis?
A2.37
A2.39
John, K; Hardtke-Wolenski, M; Jäckel, E; Manns, M; Bantel, H: Increased Apoptosis of Regulatory T Lymphocytes in Patients with Active Autoimmune Hepatitis
A2.40
A2.42
Büchter, M; Manka, P; Gerken, G; Canbay, A; Blomeyer, S; Wetter, A; Altenbernd, J; Kahraman, A; Theysohn, J: TIPS in patients with portal hypertension – patency depends on coverage
A2.43
Heinemann, M; Tafrishi, B; Pischke, S; Fischer, L; Rösch, T; Lohse, A; Sterneck, M; Denzer, U: Does long-term remission by endoscopic treatment modalities benefit patient and graft survival in biliary strictures after liver transplantation?